A formation of group of inherited immune disorders in which lymphocyte functions are impaired and lymphocyte numbers may be diminished is called Combined immune deficiencies (CIDs).These disorders affect the T-cells which disturbs their ability to provide assistance in production of antibodies and therefore causing decreased immunoglobulins. Combined immune deficiency (CID) as a result of defects caused by the gene mutations in the immune system.
The Covid-19 has a positive impact on the Combined Immune Deficiency (CID) Market. The patients with immune deficiency disorders are more prone to developing infectious diseases. The Covid-19 virus has a significant impact on the immune system leading to rising no. of patients with immune deficiency disorders seek consistent treatment.
Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=5276
Combined Immune Deficiency (CID) Market: Drivers and Restraints
The prevalence of immunodeficiency diseases is on a rise across the globe. According to a study conducted by American academy of pediatrics, the calculated prevalence of diagnosed primary immune deficiency was 1 in 2000 children and 1 in 600 households. This rise in research and development activities that focus on identifying the gene that could cause combined immune deficiency are expected to accelerate new drug development and gene-sequencing. This is expected to drive the growth of the Combined Immune Deficiency (CID) Market.
Combined Immune Deficiency (CID) Market: Segmentation
Tentatively, the global Combined Immune Deficiency (CID) Market has been segmented on the basis of disease type, therapy type and end user.
Based on disease type, the global Combined Immune Deficiency (CID) Market is segmented as:
- Antibody Deficiency
- Cellular Immunodeficiency
- Innate Immune Disorders
Based on therapy type, the global Combined Immune Deficiency (CID) Market is segmented as:
- Immunoglobulin Replacement Therapy
- Bone marrow transplant
- Stem cell transplant
- Lung transplant
- Gene therapy
Request For Customization – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5276
Based on end user, the global Combined Immune Deficiency (CID) Market is segmented as:
- Ambulatory surgical care
- Research and development institutes
Combined Immune Deficiency (CID) Market: Overview
Combined Immune Deficiency (CID) Market is expected to witness substantial growth as a result of increasing incidence of Combined Immune Deficiency globally during the forecast period.
Based on therapy type, the gene therapy is expected to dominate the Combined Immune Deficiency (CID) Market during the forecast period. The promising results of recent clinical trials is expected to make gene therapy prominent in the treatment of combined immune deficiency
In the end user segment, the hospitals are expected to hold the largest share in the Combined Immune Deficiency (CID) Market. However, the rigorous research and development activities and the increased focus of the government to encounter immune deficiency disorders is expected to lead considerable growth in the research and development segment.
Combined Immune Deficiency (CID) Market: Key players
Some of the players identified in the Combined Immune Deficiency (CID) Market include:
- LFB SA
- Shire plc
- Kedrion Biopharma Inc
- CSL Behring
- China Biologic Products Holdings, Inc
- Grifols, S.A
- Biotest AG,
- Baxter International Inc.
Explore Fact.MR’s Coverage on the Healthcare Domain:
Leukocyte Count Testing Market – According to the latest research by Fact.MR, the leukocyte count testing market is set to witness exponential growth with over 7%-8% CAGR during 2021-2031. Increasing bacterial infection with the growing adoption of point of care devices will witness a promising growth outlook for leukocyte count testing in the long run.
At-Home Celiac Testing Market – According to the Latest Research by the Fact.MR The Celiac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%. The Reason for the growth is The increase in prevalence of Celiac disease globally.
Polysaccharide Hemostatic System Market – According to the latest research by Fact.MR, Polysaccharide Hemostatic System market is set to witness a XX% growth during the year 2021-2031.
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.
US Sales Office:
11140 Rockville Pike
Rockville, MD 20852
Tel: +1 (628) 251-1583
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates